Skip to main content
Market Activity
CLOSE
Market Activity
Stocks
Funds + ETFs
Indexes
Commodities
Cryptocurrency
Currencies
Futures
Fixed Income
Global Markets
Quick Links
Real-Time Quotes
After-Hours Quotes
Pre-Market Quotes
Nasdaq-100
Symbol Screener
Online Brokers
Glossary
Sustainable Bond Network
Symbol Change History
IPO Performance
Ownership Search
Dividend History
Market Events
Economic Calendar
Earnings
IPO Calendar
Dividend Calendar
SPO Calendar
Holiday Calendar
Analyst Activity
Analyst Recommendations
Daily Earnings Surprise
Forecast Changes
Commodities
Gold
Copper
Crude Oil
Natural Gas
Nasdaq Data
Statistical Milestones
Total Returns
Daily Market Statistics
Most Active
See All Market Activity
News + Insights
CLOSE
Markets
Companies
Coronavirus
Technology
Personal Finance
Financial Advisors
Topics
Blockchain
Commodities
Cryptocurrencies
Earnings
Governance
IPOs
Retirement
Stocks
Features
World Reimagined
Smart Investing
Innovation Realized
Market Makers by Phil Mackintosh
TradeTalks
Nasdaq Watch
World Reimagined Podcast
See All News + Insights
Solutions
CLOSE
Raise & Access Capital
List with Nasdaq
Nasdaq Private Market Solutions
Investor Relations Intelligence
Optimize Governance Practices
Board Portal Software
Board Assessments & Evaluations
Nasdaq Center for Board Excellence
ESG Reporting/Data Management
Corporate Services COVID-19 Center
Directors’ and Officers’ Questionnaires
Transform with Technology
Market Infrastructure Technology
Non-Traditional Exchanges & New Markets
Sell-Side Technology
Buy-Side Technology
Catastrophe Risk Modelling
Gain Market Intelligence
Buy-Side Intelligence
Investment Data & Analytics
Market Data & Feeds
Nasdaq Global Indexes
Institutional Capital with eVestment
Trade Global Markets
Equities
Equity Derivatives
ETFs & ETPs
Fixed Income
Commodities
Connectivity
Post Trade Services
Clearing
Exchange Oversight
Sustainable Bonds
See All Solutions
About
CLOSE
Our People
Careers
Press Center
Contact
Quick Links
Diversity, Inclusion and Belonging
Nasdaq Marketsite
Investor Relations
ESG Reporting Guide
European Markets
Nasdaq Nordic Foundation
Nasdaq Thought Leadership
Nasdaq Initiatives
Nasdaq Responds to Covid-19
TotalMarkets
Public Policy Advocacy
Sustainability at Nasdaq
Nasdaq Entrepreneurial Center
Nasdaq Ventures
Nasdaq and the Cloud
See All About
Log in
Data is currently not available
Data is currently not available
Find a Symbol
Search for Press Releases
When autocomplete results are available use up and down arrows to review and enter to select. Touch device users, explore by touch or with swipe gestures.
Edit my quotes
HOOKIPA Pharma Inc. Common Stock
(HOOK)
Nasdaq
Listed
Nasdaq
100
Data is currently not available
Add to Watchlist
Add to Portfolio
Quotes
Summary
Live
Real-Time
Live
After-Hours
Live
Pre-Market
Live
Charts
Live
NEWS & ANALYSIS
News
Live
Press Releases
Live
Analyst Research
Live
Dividend History
Historical Quotes
Historical NOCP
Financials
Earnings
P/E & PEG Ratios
Option Chain
Short Interest
Institutional Holdings
Insider Activity
SEC Filings
Revenue EPS
HOOK
HOOK PRESS RELEASES
HOOK Press Releases
Published
Feb 16, 2021
HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference
Published
Feb 16, 2021
Published
Dec 11, 2020
HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option
Published
Dec 11, 2020
Published
Dec 8, 2020
HOOKIPA Pharma Announces Pricing of Public Offering of Common Stock and Preferred Stock
Published
Dec 8, 2020
Published
Dec 8, 2020
HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock
Published
Dec 8, 2020
Published
Dec 7, 2020
HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability
Published
Dec 7, 2020
Published
Nov 30, 2020
HOOKIPA Announces Positive Phase 2 Interim Safety, Immunogenicity, and Efficacy Data for its Cytomegalovirus Vaccine Candidate HB-101
Published
Nov 30, 2020
Published
Nov 12, 2020
HOOKIPA Pharma Reports Third Quarter 2020 Financial Results and Provides a Corporate Update
Published
Nov 12, 2020
Published
Nov 11, 2020
HOOKIPA Pharma to Participate in Upcoming Investor Conferences in November
Published
Nov 11, 2020
Published
Nov 3, 2020
HOOKIPA Pharma To Report Third Quarter 2020 Financial Results on November 12, 2020
Published
Nov 3, 2020
Published
Oct 29, 2020
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-202/HB-201 Alternating Vector Therapy to Treat Human Papillomavirus 16-Positive Cancers
Published
Oct 29, 2020
Published
Oct 19, 2020
HOOKIPA Appoints Prof. Jean-Charles Soria, Director General of the Gustave Roussy Cancer Center in Paris, to its Board of Directors
Published
Oct 19, 2020
Published
Sep 16, 2020
HOOKIPA Pharma’s LCMV-based Immunotherapy for HPV16+ Cancers Demonstrates High Immunogenicity, According to Peer Reviewed Article
Published
Sep 16, 2020
Published
Sep 16, 2020
HOOKIPA Pharma to Present at SVB Leerink’s CybeRx Series Vaccine Forum
Published
Sep 16, 2020
Published
Sep 9, 2020
HOOKIPA Pharma to Present at Upcoming Conferences in September
Published
Sep 9, 2020
Published
Aug 13, 2020
HOOKIPA Pharma Reports Second Quarter 2020 Financial Results and Provides a Corporate Update
Published
Aug 13, 2020
Published
Aug 4, 2020
HOOKIPA Pharma To Report Second Quarter 2020 Financial Results on August 13, 2020
Published
Aug 4, 2020
Published
Aug 3, 2020
HOOKIPA Announces Issuance of US and European Patents
Published
Aug 3, 2020
Published
Jun 22, 2020
HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB‑101
Published
Jun 22, 2020
Published
Jun 19, 2020
HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer
Published
Jun 19, 2020
Published
Jun 17, 2020
HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers
Published
Jun 17, 2020
...
Back to HOOK Overview
Related Symbols
GME
Data is currently not available
AAPL
Data is currently not available
TSLA
Data is currently not available
AMC
Data is currently not available
My Quotes
My Quotes
Watchlist
Portfolio
Add/Edit Symbols
View as Table
Add symbols
now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing
stocks
,
funds and ETFs
, and
more asset classes.
/
Add/Edit Symbols
Edit Watchlist
Your Watchlist is empty.
Add/Edit Symbols
Create your Watchlist to save your favorite quotes on Nasdaq.com.
Log in
or
create a free account
to get started.
/
Outsmart the market with Smart Portfolio analytical tools powered by TipRanks.
Go to Smart Portfolio
Back
Add a symbol to your watchlist
Most Active
Data is currently not available
Edit My Quotes
Add up to 25 symbols
To add symbols:
Type a symbol or company name. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return.
Copy and paste multiple symbols separated by spaces.
These symbols will be available throughout the site during your session.
Save data
Data is currently not available
Your symbols have been updated
You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.
Continue
Data is currently not available
Edit Watchlist
Add up to 20 symbols
To add symbols:
Type a symbol or company name. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return.
Copy and paste multiple symbols separated by spaces.
These symbols will be available throughout the site during your session.
Save data